STUART, Fla., June 22 /PRNewswire-FirstCall/ — Liberator Medical Supply, Inc. (“Liberator”), announced today the execution of a definitive merger agreement with Liberator Medical Holdings, Inc. (BULLETIN BOARD: LBMH) (formerly Cardiff Communications, Inc.) (BULLETIN BOARD: CDFO) . On completion of the merger, Liberator will become a wholly-owned subsidiary of Liberator Medical Holdings, Inc. and Liberator’s shareholders will become shareholders of Liberator Medical Holdings, Inc.
Mark Libratore, President and Chief Executive Officer of Liberator, stated, “We are very excited about completing this phase of our growth plan and the opportunity for Liberator and our shareholders to become part of a fully-reporting public company.”
Mark Libratore’s past successes as a leading provider of home health care equipment are well-known in the industry. As founder of Liberty Medical Supply, Inc., the nation’s largest direct-to-consumer diabetic supplier, his innovative use of national advertising on TV and other media quickly grew a national customer base.
“With the expertise of our management team,” stated Mark Libratore, “we plan to further increase our capabilities of providing home healthcare equipment directly to consumers, and deliver long-term value to our shareholders by rapidly increasing our national market share.” Liberator’s ability to fulfill orders nationally is greatly facilitated by operating its customer call center and direct-distribution warehousing at its Florida corporate headquarters.
About Liberator Medical Supply, Inc.
Liberator Medical Supply, Inc. is a national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider Accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. The Company is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Approximately 75% of its revenue comes from supplying products to meet the rapidly growing requirements of Diabetes, Urological, Ostomy and Mastectomy patients. The Company communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
This press release contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward- looking statements are commonly identified by such terms as “believes,””anticipates,””estimates,””expects,” and other terms with similar meaning, and are subject to risks and uncertainties which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, changes in Medicare reimbursement, the Company’s ability to participate in new reimbursement programs, the outcome of governmental agency reviews, inquiries, investigations and related litigation, continued compliance with governmental regulations, fluctuations in customer demand, management of rapid growth, competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions, geopolitical events and regulatory change. The information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release.
http://www.liberatormedical.com/
Liberator Medical Supply, Inc.
CONTACT: Mark Libratore, President and Chairman of the Board ofLiberator Medical Supply, Inc., +1-772-287-2414, [email protected]
Web site: http://www.liberatormedical.com/
Comments